Skip to main content
. 2017 Apr 19;108(4):632–640. doi: 10.1111/cas.13196

Figure 1.

Figure 1

SOX2 expression is correlated with histological grade and poor prognosis in endometrial cancer. (a) Representative immunostaining results for SOX2 (score 0–3). Scale bars: 100 μm. (b) Distribution of SOX2 expression in different histological grades of endometrial cancer (n = 258). (c,d). Kaplan–Meier analyses of progression‐free survival (c) and overall survival (d) in patients with advanced‐stage endometrial cancer. The patients were stratified into SOX2‐positive (red lines, n = 8) and SOX2‐negative (blue lines, n = 23) groups.